These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 27699410)
21. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. Karasu B Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389 [TBL] [Abstract][Full Text] [Related]
22. Rapid resolution of retinoschisis with acetazolamide. Zhang L; Reyes R; Lee W; Chen CL; Chan L; Sujirakul T; Chang S; Tsang SH Doc Ophthalmol; 2015 Aug; 131(1):63-70. PubMed ID: 25796216 [TBL] [Abstract][Full Text] [Related]
23. TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS. Schmitt MA; Wang K; DeBenedictis MJ; Traboulsi EI Retina; 2022 Nov; 42(11):2176-2183. PubMed ID: 35982512 [TBL] [Abstract][Full Text] [Related]
24. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Fishman GA; Apushkin MA Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269 [TBL] [Abstract][Full Text] [Related]
25. Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors. Chen JJ; Sohn EH; Folk JC; Mahajan VB; Kay CN; Boldt HC; Russell SR Retina; 2014 Jul; 34(7):1400-6. PubMed ID: 24451922 [TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibition in X-linked retinoschisis: An eye on the photoreceptors. Ambrosio L; Williams JS; Gutierrez A; Swanson EA; Munro RJ; Ferguson RD; Fulton AB; Akula JD Exp Eye Res; 2021 Jan; 202():108344. PubMed ID: 33186570 [TBL] [Abstract][Full Text] [Related]
27. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome. Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis. Huang Q; Chen R; Lin X; Xiang Z PLoS One; 2017; 12(10):e0186180. PubMed ID: 29023491 [TBL] [Abstract][Full Text] [Related]
29. Wide-field spectral-domain optical coherence tomography in patients and carriers of X-linked retinoschisis. Gregori NZ; Lam BL; Gregori G; Ranganathan S; Stone EM; Morante A; Abukhalil F; Aroucha PR Ophthalmology; 2013 Jan; 120(1):169-74. PubMed ID: 23009889 [TBL] [Abstract][Full Text] [Related]
31. Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months. Pennesi ME; Birch DG; Jayasundera KT; Parker M; Tan O; Gurses-Ozden R; Reichley C; Beasley KN; Yang P; Weleber RG; Bennett LD; Heckenlively JR; Kothapalli K; Chulay JD; For The Xlrs-Study Group Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5941-5956. PubMed ID: 30551202 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of topical brinzolamide in children with retinal dystrophies. Scruggs BA; Chen CV; Pfeifer W; Wiley JS; Wang K; Drack AV Ophthalmic Genet; 2019 Aug; 40(4):350-358. PubMed ID: 31496370 [No Abstract] [Full Text] [Related]
33. Phenotypic Characteristics of a French Cohort of Patients with X-Linked Retinoschisis. Orès R; Mohand-Said S; Dhaenens CM; Antonio A; Zeitz C; Augstburger E; Andrieu C; Sahel JA; Audo I Ophthalmology; 2018 Oct; 125(10):1587-1596. PubMed ID: 29739629 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series. Durmaz Engin C; Ekinci UB; Selver A; Saatci AO Turk J Ophthalmol; 2020 Mar; 50(1):44-49. PubMed ID: 32167263 [TBL] [Abstract][Full Text] [Related]
35. Paradoxical response to carbonic anhydrase inhibitors in patients with intraretinal cystoid spaces. Guimaraes TAC; Capasso JE; Levin AV Ophthalmic Genet; 2019 Jun; 40(3):213-218. PubMed ID: 31266384 [No Abstract] [Full Text] [Related]
36. Treatment of cystic macular lesions in hereditary retinal dystrophies. Salvatore S; Fishman GA; Genead MA Surv Ophthalmol; 2013; 58(6):560-84. PubMed ID: 24160730 [TBL] [Abstract][Full Text] [Related]
37. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report. Hong EH; Ahn SJ; Lim HW; Lee BR BMC Ophthalmol; 2017 Jul; 17(1):124. PubMed ID: 28701214 [TBL] [Abstract][Full Text] [Related]
38. Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa. Shimokawa S; Fujiwara K; Murakami Y; Funatsu J; Nakatake S; Yoshida N; Sonoda KH; Ikeda Y Ophthalmol Retina; 2020 Oct; 4(10):1036-1039. PubMed ID: 32454228 [No Abstract] [Full Text] [Related]
39. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259 [TBL] [Abstract][Full Text] [Related]
40. In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition. Zhour A; Bolz S; Grimm C; Willmann G; Schatz A; Weber BH; Zrenner E; Fischer MD Vet Ophthalmol; 2012 Sep; 15 Suppl 2():123-33. PubMed ID: 22672048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]